Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lidocaine-epinephrine versus prilocaine-felypressin for blood glucose changes during dental local anesthesia
IRCT20250714066485N1Phase 3Completed
- Sponsor
- Kurdistan University of Medical Sciences
- Start
- Aug 2025
- Modality
- Small Molecules, Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
Phase 3, double-blind trial of lidocaine, epinephrine, prilocaine and felypressin (2 arms), sponsored by Kurdistan University of Medical Sciences. Primary endpoint: Blood glucose. Started Aug 2025; status: completed.
02
Drugs
lidocaineepinephrineprilocainefelypressin
Beyond the preview
Go deeper on IRCT20250714066485N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20250714066485N1.